TforG

OpenApp is an innovative software development company that focuses on the healthcare sector. Their specialties lie in utilizing open-source tools to deliver applications, systems & solutions. With extensive experience in health intelligence, geographic information, patient registries, and document management.

Pharmaspectra, LLC is a global provider of medical key opinion leader databases and scientific dissemination data for the healthcare, pharmaceutical, and biotechnology sectors. The company offers a range of tools, including ProfileMeme, which enables users to search, sort, rank, and analyze key opinion leader profiles in medical and biological sciences. Additionally, ConferenceMeme helps users organize and target medical conferences, while JournalMeme serves as an online platform for identifying and contacting advocates and researchers. Pharmaspectra’s Knowledge Discovery Platform tracks medical meetings and clinical research presentations, and MEPmeme provides updated information on medical education providers. Founded in 2004 and based in New York, Pharmaspectra was previously known as MedMeme, LLC before rebranding in August 2018.

AllCare Plus Pharmacy is a specialty pharmacy based in Northborough, MA, dedicated to providing a comprehensive range of pharmacy services with a focus on complex medication management. The pharmacy emphasizes personalized care, combining exceptional clinical expertise with innovative compliance programs to simplify the treatment of challenging diseases. In addition to its core pharmacy services, AllCare Plus Pharmacy offers robust patient support services, including reimbursement support, adherence assistance, and financial aid. The company utilizes an integrated technology platform to enhance its offerings, ensuring that clients receive the necessary support to manage difficult conditions effectively and safely.

RxWare is a software-as-a-service (SaaS) company founded in 2013 that focuses on improving the patient experience for pharmaceutical drug manufacturers. The company offers a Patient Gateway, a digital infrastructure that connects various patient services and organizations, such as ePrescribing systems, specialty pharmacies, and affordability solutions. By facilitating out-of-the-box connectivity, RxWare enables pharmaceutical brands to simplify complex patient journeys, ultimately enhancing therapy outcomes and resource utilization. Additionally, its platform includes a mobile intelligence tool designed to assist individuals with diabetes by providing information on symptoms, management, and dietary recommendations, further supporting the goal of streamlining and accelerating the patient journey.

BC Platforms is a technology company that specializes in providing a unique data and technology platform for life sciences and healthcare companies. Their Data Access Platform offers access to valuable real-world data (RWD), clinical, genomics, and omics data through a data-as-a-service model. This enables pharmaceutical companies to enhance various use cases within the research and development continuum, from early discovery to post-market processes. The company's technology platform also supports healthcare providers and life science companies in producing, managing, and analyzing complex genomic data as a clinical decision-support solution. BC Platforms' Data Partner Network covers over 22 million life-years of highly curated patient data from around the world, ensuring compatibility with relevant technical standards and compliance with local privacy laws.

Octopus.Health is a patient engagement platform for proactive population health. The company technology creates a Healthcare Personal Assistant that supports millions of patients and tailors a personalized proactive healthcare plan for each patient based on advanced machine learning algorithms. Octopus.Health leverages AI and Machine Learning to revolutionize how patient adherence is being managed today. It was founded in 2017 and is based in Tel Aviv, Israel.

Founded in 2015 by Eliran Malki, Irad Deutsch, and Ohad Rubin, Belong.Life is a leader in healthcare technology, focusing on patient engagement and navigation. The company developed a free app called Belong, designed to assist cancer patients and their support networks in managing their treatment journeys and enhancing their quality of life. Belong.Life also offers a comprehensive solution for healthcare organizations through its PEP platform, which includes personalized patient engagement tools and navigation services. Utilizing proprietary artificial intelligence and machine learning algorithms, the platform streamlines patient navigation, provides treatment templates and reminders, and maps patient journeys to share valuable insights, ultimately aiming to improve healthcare delivery and patient outcomes.

Linguamatics Limited is a software company that specializes in developing text mining solutions utilizing semantic and natural language processing technologies for the life sciences, pharmaceutical, and biotech industries. Founded in 2001 and headquartered in Cambridge, United Kingdom, with additional operations in Newton, Massachusetts, the company offers a range of products including its I2E platform, which enables agile querying and reporting to extract critical insights from large text collections. Linguamatics Health, a clinical natural language processing suite, helps healthcare organizations analyze unstructured data from electronic health records and patient narratives to enhance research and patient outcomes. The company's solutions are designed to facilitate knowledge discovery and decision support across various resources, including scientific literature and patents, ultimately accelerating drug development while reducing costs and improving quality. Linguamatics operates as a subsidiary of IQVIA Holdings Inc.

Beijing Naxions Technology Co., Ltd. specializes in providing digital marketing services tailored for the medical Internet industry. Founded in 2014 and headquartered in Chaoyang District, China, with additional offices in Shanghai, the company has developed a communication software solution that incorporates a SaaS platform. This platform enables real-time data analysis, project management, and customer insights while streamlining processes such as data capture, collection, scraping, cleaning, calculation, and presentation. Naxions focuses on enhancing efficiency for pharmaceutical companies by leveraging advanced semantic understanding and deep learning algorithms to improve sales management and bolster brand image through innovative internet technologies.

Advanced Health Media provides software solutions and services to manage healthcare professional (HCP) engagements for pharmaceutical companies and life science industries worldwide. The company offers a range of products, including CentrisDirect for managing the HCP engagement ecosystem, CentrisEngage for meeting and engagement management, CentrisConnect for customer-centric data viewing and management, CentrisServices for meeting and engagement services, CentrisIQ for business intelligence reporting, and CentrisExchange for third-party solution connectors. Advanced Health Media serves over 25 pharmaceutical companies, managing more than 150,000 events annually and having completed over one million pharmaceutical events since 2005. The company is headquartered in New Providence, New Jersey, with additional locations in Norfolk, Virginia; Manila, Philippines; and London, United Kingdom. Founded in 1999, Advanced Health Media has several hundred employees committed to investing in solutions that enhance customer experience, advance strategic decision-making, and ensure comprehensive compliance reporting.

ObvioHealth is a global digital health organization focused on enhancing clinical trials through innovative technology. The company provides a mobile clinical study application that facilitates site-less trial designs, enabling participants to engage in remote monitoring from their homes. This application supports continuous data collection between clinic visits, ensuring robust data acquisition and improved participant compliance. By utilizing features such as text messaging and chatbots, ObvioHealth fosters daily interaction with trial subjects, enhancing their involvement in the process. The platform also integrates seamlessly with various health devices, including smartwatches and activity trackers, which aids in collecting real-world data. Additionally, participants can manage lab visit scheduling and receive compensation through their connected accounts. By streamlining communication through chat or video, ObvioHealth significantly improves the clinical trial experience for both sponsors and participants, leading to faster recruitment and reduced trial completion times.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

DrugDev is a technology-driven company that offers a range of solutions designed to enhance the efficiency and collaboration in clinical trials. It operates the largest online network of clinical trial sites and provides a leading platform for investigator identification and startup processes. By integrating trial optimization systems and grants payment capabilities, DrugDev transforms how drug developers identify, engage, and compensate doctors involved in clinical research. The company also hosts the Investigator Databank, a collaborative initiative among major pharmaceutical companies aimed at increasing clinical trial opportunities and alleviating the administrative burdens faced by over 200,000 clinical trial professionals globally. Through its data-sharing platform, DrugDev fosters communication among doctors, contract research organizations, and investigators, promoting standards that enhance quality, reduce costs, and streamline timelines in clinical trials.

Pilgrim Quality Solutions, Inc. is a provider of enterprise quality management software solutions tailored for the life sciences industry and other highly regulated sectors. Founded in 1993 and based in Tampa, Florida, the company specializes in its flagship product, SmartSolve, a web-based suite designed to enhance quality, ensure regulatory compliance, and mitigate risks. SmartSolve facilitates various functions including quality management, compliance management, and risk management, and can be deployed on-premise or in the cloud. In addition to its software offerings, Pilgrim provides professional services such as technical support, training, and validation assistance. The company has built a strong reputation for innovation and excellence, serving a diverse global clientele, including industries beyond life sciences, such as automotive and aerospace. Pilgrim's solutions enable organizations to manage their operations effectively, ensuring product safety and compliance while improving overall customer satisfaction.

Themis Analytics is a company specializing in data analytics services within the pharmaceutical industry. It provides a platform that enables clients to check, integrate, and harmonize a wide range of pharmaceutical market data. The company focuses on data management, visualization, reporting, and alerts, ensuring decision-makers can access critical information to make informed and strategic decisions. Themis Analytics aims to enhance efficiency and effectiveness in the management of pharmaceutical data, supporting clients throughout the entire data life cycle.

STI Technologies is a healthcare-focused company that specializes in managing patient support programs and enhancing medication access. By utilizing available reimbursement funding and innovative technology, it engages patients in their healthcare journey. The company develops intelligent solutions designed to support various stakeholders within the healthcare system, offering financial reimbursement, patient engagement, and patient management services aimed at improving health outcomes. STI Technologies provides user-friendly solutions accessible online as well as through healthcare providers such as physicians and pharmacists across the country. Additionally, the company has expanded its capabilities by acquiring a business that offers software development and managed network support services.

ClioScience is a drug-raising venture company that develops of anti-cancer drugs and orphan drugs such as doctor-led clinical trials.

Aileron Solutions, LLC specializes in providing data and analytics services tailored for pharmaceutical and medical device manufacturers. Founded in 2009 and headquartered in Conshohocken, Pennsylvania, the company offers a range of data products, including precision targeting claims data that enables physician-level targeting in various healthcare settings, as well as physician affiliations and reference data. Aileron Solutions also delivers advanced analytics services focused on physician influence and network affiliations. Additionally, the company offers support services such as data matching, deduplication of records, validation, and enhancement of existing data. With a comprehensive approach to healthcare data solutions, Aileron Solutions strives to empower clients with valuable insights for effective decision-making in the healthcare landscape.

Novella is a specialty contract research organization (CRO) dedicated to addressing the unique needs of small to mid-sized oncology companies, as well as medical device and diagnostics firms. The company has developed a flexible business model that includes global capabilities and a therapeutically-aligned staff, ensuring a comprehensive understanding of the specific requirements associated with oncology and medical device trials. In addition to its CRO services, Novella also operates as an organizational agency, facilitating communication among stakeholders, arranging conferences, and publishing customized materials for various organizations. This dual focus allows Novella to provide specialized support that enhances the efficiency and effectiveness of clinical research in the oncology and medical device sectors.